The temperature stability of mouse retroviruses depends on the cholesterol levels of viral lipid shell and cellular plasma membrane

被引:35
作者
Beer, C [1 ]
Meyer, A [1 ]
Müller, K [1 ]
Wirth, M [1 ]
机构
[1] GBF, German Res Ctr Biotechnol, Dept Mol Biotechnol, D-38124 Braunschweig, Germany
关键词
mouse leukemia virus 4070A; retrovirus; temperature stability; cholesterol; lipid composition; extracellular half-life time;
D O I
10.1016/S0042-6822(02)00087-9
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
To delineate parameters contributing to the extracellular lifetime of retroviral vectors, we carried out stability tests of retroviruses derived from cell lines of different origin and kept under different cultivation conditions. Results show that amphotropic mouse retroviruses (MLV-A) derived from human and hamster cells exhibit 2- to 3-fold higher half-lives compared to retroviruses from mouse cells. Cultivation at 32degreesC has been reported to yield high virus titers. However, the benefit of virus production in mouse cells at 32degreesC is controversial. In our hands the cultivation temperature affected, hitherto not noticed, the half-life time of MLV-A. The 37/32degreesC shift resulted in a 3-fold decrease of viral half-lifes compared to MLV-A released from mouse cells at 37degreesC. Thus, MLV-A released at 37degreesC is phenotypically different from MLV-A synthesized at 32degreesC. Increased virus stability was inversely correlated with the level of cholesterol in the viral membrane. Finally, depletion of viral cholesterol in vitro resulted in intact virus with increased thermal stability. Thus, retrovirus lability depends on the host cell and parallels the cholesterol amount in the viral lipid shell. (C) 2003 Elsevier Science (USA). All rights reserved.
引用
收藏
页码:137 / 146
页数:10
相关论文
共 38 条
[1]   LIPID-COMPOSITION AND FLUIDITY OF THE HUMAN-IMMUNODEFICIENCY-VIRUS ENVELOPE AND HOST-CELL PLASMA-MEMBRANES [J].
ALOIA, RC ;
TIAN, HR ;
JENSEN, FC .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1993, 90 (11) :5181-5185
[2]   Toward a more accurate quantitation of the activity of recombinant retroviruses: Alternatives to titer and multiplicity of infection [J].
Andreadis, S ;
Lavery, T ;
Davis, HE ;
le Doux, JM ;
Yarmush, ML ;
Morgan, JR .
JOURNAL OF VIROLOGY, 2000, 74 (03) :1258-1266
[3]   Moloney murine leukemia virus-derived retroviral vectors decay intracellularly with a half-life in the range of 5.5 to 7.5 hours [J].
Andreadis, ST ;
Brott, D ;
Fuller, AO ;
Palsson, BO .
JOURNAL OF VIROLOGY, 1997, 71 (10) :7541-7548
[4]   HIGH-TITER PACKAGING CELLS PRODUCING RECOMBINANT RETROVIRUSES RESISTANT TO HUMAN SERUM [J].
COSSET, FL ;
TAKEUCHI, Y ;
BATTINI, JL ;
WEISS, RA ;
COLLINS, MKL .
JOURNAL OF VIROLOGY, 1995, 69 (12) :7430-7436
[5]   Modeling retrovirus production for gene therapy. 1. Determination of optimal bioreaction mode and harvest strategy [J].
Cruz, PE ;
Almeida, JS ;
Murphy, PN ;
Moreira, JL ;
Carrondo, MJT .
BIOTECHNOLOGY PROGRESS, 2000, 16 (02) :213-221
[6]   COLD SHOCK DAMAGE IS DUE TO LIPID PHASE-TRANSITIONS IN CELL-MEMBRANES - A DEMONSTRATION USING SPERM AS A MODEL [J].
DROBNIS, EZ ;
CROWE, LM ;
BERGER, T ;
ANCHORDOGUY, TJ ;
OVERSTREET, JW ;
CROWE, JH .
JOURNAL OF EXPERIMENTAL ZOOLOGY, 1993, 265 (04) :432-437
[7]   RETROVIRAL-MEDIATED GENE-TRANSFER INTO HEPATOCYTES INVIVO [J].
FERRY, N ;
DUPLESSIS, O ;
HOUSSIN, D ;
DANOS, O ;
HEARD, JM .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1991, 88 (19) :8377-8381
[8]  
Forestell SP, 1995, GENE THER, V2, P723
[9]   CONSTRUCTION OF STABLE BHK-21-CELLS COEXPRESSING HUMAN SECRETORY GLYCOPROTEINS AND HUMAN GAL(BETA-1-4)GLCNAC-R ALPHA-2,6-SIALYLTRANSFERASE ALPHA-2,6-LINKED NEUAC IS PREFERENTIALLY ATTACHED TO THE GAL(BETA-1-4)GLCNAC(BETA-1-2)MAN(ALPHA-1-3)-BRANCH OF DIANTENNARY OLIGOSACCHARIDES FROM SECRETED RECOMBINANT BETA-TRACE PROTEIN [J].
GRABENHORST, E ;
HOFFMANN, A ;
NIMTZ, M ;
ZETTLMEISSL, G ;
CONRADT, HS .
EUROPEAN JOURNAL OF BIOCHEMISTRY, 1995, 232 (03) :718-725
[10]   Optimized conditions for the production of recombinant amphotropic retroviral vector preparations [J].
Kaptein, LCM ;
Greijer, AE ;
Valerio, D ;
vanBeusechem, VW .
GENE THERAPY, 1997, 4 (02) :172-176